Innovating at Unprecedented Pace COVID-19 prompted dramatic changes in the way we conduct research. In the months since the pandemic began, we have completed literally…
John EvansFebruary 8, 2021
Latest News
On 28 Feb. 2020, the US Food and Drug Administration (FDA) approved a novel fixed-dose combination oral pain reliever (Advil Dual Action with Acetaminophen) for…
John EvansMarch 5, 2020
An analysis of the use of time sampling strategies (subject reports of medication dosing behavior in the period preceding a study contact) compared to daily…
John EvansSeptember 15, 2019
On November 7, 2018, FDA’s CDER approved a new version of Primatene Mist as the only OTC metered-dose inhaler. Primatene is for the temporary relief…
John EvansJanuary 28, 2019
Key staff from PEGUS (Dr. Russ Bradford, Sarah Farnsworth, Kimberly Anderson and Clark Richardson) participated in an innovative session at the 2018 Regulatory, Scientific and…
John EvansJune 27, 2018
On April 17, members of the PEGUS scientific consulting team participated in the CHPA Consumer Behavior Roundtable in Silver Spring, Maryland. The roundtable was attended…
John EvansJune 27, 2018
A Self-Selection and Actual Use Trial conducted by PEGUS Research that investigated whether consumers can correctly select and use a long-acting immediate-release and extended-release 600…
John EvansJune 27, 2018
Learn more about PEGUS
Our Pharmaceutical Research Services
Learn More
Join our Pharmacy Network.
Are you a registered pharmacist interested in joining our network?
Learn More
